Literature DB >> 23223282

Stress produces aversion and potentiates cocaine reward by releasing endogenous dynorphins in the ventral striatum to locally stimulate serotonin reuptake.

Abigail G Schindler1, Daniel I Messinger, Jeffrey S Smith, Haripriya Shankar, Richard M Gustin, Selena S Schattauer, Julia C Lemos, Nicholas W Chavkin, Catherine E Hagan, John F Neumaier, Charles Chavkin.   

Abstract

Activation of the dynorphin/κ-opioid receptor (KOR) system by repeated stress exposure or agonist treatment produces place aversion, social avoidance, and reinstatement of extinguished cocaine place preference behaviors by stimulation of p38α MAPK, which subsequently causes the translocation of the serotonin transporter (SERT, SLC6A4) to the synaptic terminals of serotonergic neurons. In the present study we extend those findings by showing that stress-induced potentiation of cocaine conditioned place preference occurred by a similar mechanism. In addition, SERT knock-out mice did not show KOR-mediated aversion, and selective reexpression of SERT by lentiviral injection into the dorsal raphe restored the prodepressive effects of KOR activation. Kinetic analysis of several neurotransporters demonstrated that repeated swim stress exposure selectively increased the V(max) but not K(m) of SERT without affecting dopamine transport or the high-capacity, low-affinity transporters. Although the serotonergic neurons in the dorsal raphe project throughout the forebrain, a significant stress-induced increase in cell-surface SERT expression was only evident in the ventral striatum, and not in the dorsal striatum, hippocampus, prefrontal cortex, amygdala, or dorsal raphe. Stereotaxic microinjections of the long-lasting KOR antagonist norbinaltorphimine demonstrated that local KOR activation in the nucleus accumbens, but not dorsal raphe, mediated this stress-induced increase in ventral striatal surface SERT expression. Together, these results support the hypothesis that stress-induced activation of the dynorphin/KOR system produces a transient increase in serotonin transport locally in the ventral striatum that may underlie some of the adverse consequences of stress exposure, including the potentiation of the rewarding effects of cocaine.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23223282      PMCID: PMC3523715          DOI: 10.1523/JNEUROSCI.3220-12.2012

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  88 in total

1.  Epiblast-restricted Cre expression in MORE mice: a tool to distinguish embryonic vs. extra-embryonic gene function.

Authors:  M D Tallquist; P Soriano
Journal:  Genesis       Date:  2000-02       Impact factor: 2.487

2.  Selective destruction of brain serotonin neurons by 5,7-dihydroxytryptamine increases responding for a conditioned reward.

Authors:  P J Fletcher; K M Korth; J W Chambers
Journal:  Psychopharmacology (Berl)       Date:  1999-12       Impact factor: 4.530

3.  Effects of naltrexone and fluoxetine on alcohol self-administration and reinstatement of alcohol seeking induced by priming injections of alcohol and exposure to stress.

Authors:  A D Lê; C X Poulos; S Harding; J Watchus; W Juzytsch; Y Shaham
Journal:  Neuropsychopharmacology       Date:  1999-09       Impact factor: 7.853

4.  Behavioral, neuroendocrine and serotonergic consequences of single social defeat and repeated fluoxetine pretreatment in the Lewis rat strain.

Authors:  O Berton; M Durand; S Aguerre; P Mormède; F Chaouloff
Journal:  Neuroscience       Date:  1999       Impact factor: 3.590

5.  Stressor-induced alterations in serotonergic activity in an animal model of depression.

Authors:  T J Connor; C Song; B E Leonard; H Anisman; Z Merali
Journal:  Neuroreport       Date:  1999-02-25       Impact factor: 1.837

6.  Reboxetine attenuates forced swim test-induced behavioural and neurochemical alterations in the rat.

Authors:  T J Connor; P Kelliher; A Harkin; J P Kelly; B E Leonard
Journal:  Eur J Pharmacol       Date:  1999-08-27       Impact factor: 4.432

7.  Striatal dopamine transporter density in major depression.

Authors:  T Laasonen-Balk; J Kuikka; H Viinamäki; M Husso-Saastamoinen; J Lehtonen; J Tiihonen
Journal:  Psychopharmacology (Berl)       Date:  1999-06       Impact factor: 4.530

8.  Hippocampal and striatal [(3)H]5-HT reuptake under acute stressors in two rat strains differing for their emotivity.

Authors:  C Martin; M Duclos; P Mormède; G Manier; F Chaouloff
Journal:  Neurosci Lett       Date:  2000-07-21       Impact factor: 3.046

9.  Improgan, a cimetidine analog, induces morphine-like antinociception in opioid receptor-knockout mice.

Authors:  L B Hough; J W Nalwalk; Y Chen; A Schuller; Y Zhu; J Zhang; W M Menge; R Leurs; H Timmerman; J E Pintar
Journal:  Brain Res       Date:  2000-10-13       Impact factor: 3.252

10.  Cellular sites for dynorphin activation of kappa-opioid receptors in the rat nucleus accumbens shell.

Authors:  A L Svingos; E E Colago; V M Pickel
Journal:  J Neurosci       Date:  1999-03-01       Impact factor: 6.167

View more
  48 in total

1.  Modulation of serotonin transporter function by kappa-opioid receptor ligands.

Authors:  Santhanalakshmi Sundaramurthy; Balasubramaniam Annamalai; Devadoss J Samuvel; Toni S Shippenberg; Lankupalle D Jayanthi; Sammanda Ramamoorthy
Journal:  Neuropharmacology       Date:  2016-10-12       Impact factor: 5.250

2.  Effects of kappa opioid receptors on conditioned place aversion and social interaction in males and females.

Authors:  Cindee F Robles; Marissa Z McMackin; Katharine L Campi; Ian E Doig; Elizabeth Y Takahashi; Michael C Pride; Brian C Trainor
Journal:  Behav Brain Res       Date:  2014-01-18       Impact factor: 3.332

Review 3.  Stress, sex, and motivated behaviors.

Authors:  Abigail Laman-Maharg; Brian C Trainor
Journal:  J Neurosci Res       Date:  2017-01-02       Impact factor: 4.164

Review 4.  Opioid modulation of cognitive impairment in depression.

Authors:  Moriah L Jacobson; Hildegard A Wulf; Caroline A Browne; Irwin Lucki
Journal:  Prog Brain Res       Date:  2018-09-18       Impact factor: 2.453

Review 5.  Kappa-Opioid Antagonists for Psychiatric Disorders: From Bench to Clinical Trials.

Authors:  William A Carlezon; Andrew D Krystal
Journal:  Depress Anxiety       Date:  2016-10       Impact factor: 6.505

6.  κ Opioid receptors in the nucleus accumbens shell mediate escalation of methamphetamine intake.

Authors:  Timothy W Whitfield; Joel E Schlosburg; Sunmee Wee; Adam Gould; Olivier George; Yanabel Grant; Eva R Zamora-Martinez; Scott Edwards; Elena Crawford; Leandro F Vendruscolo; George F Koob
Journal:  J Neurosci       Date:  2015-03-11       Impact factor: 6.167

7.  Estrogen Regulation of GRK2 Inactivates Kappa Opioid Receptor Signaling Mediating Analgesia, But Not Aversion.

Authors:  Antony D Abraham; Selena S Schattauer; Kathryn L Reichard; Joshua H Cohen; Harrison M Fontaine; Allisa J Song; Salina D Johnson; Benjamin B Land; Charles Chavkin
Journal:  J Neurosci       Date:  2018-08-03       Impact factor: 6.167

Review 8.  The multiple facets of opioid receptor function: implications for addiction.

Authors:  Pierre-Eric Lutz; Brigitte L Kieffer
Journal:  Curr Opin Neurobiol       Date:  2013-02-28       Impact factor: 6.627

Review 9.  Sex Differences in Trauma-Related Psychopathology: a Critical Review of Neuroimaging Literature (2014-2017).

Authors:  Liat Helpman; Xi Zhu; Benjamin Suarez-Jimenez; Amit Lazarov; Catherine Monk; Yuval Neria
Journal:  Curr Psychiatry Rep       Date:  2017-11-08       Impact factor: 5.285

Review 10.  Dynorphin--still an extraordinarily potent opioid peptide.

Authors:  Charles Chavkin
Journal:  Mol Pharmacol       Date:  2012-11-14       Impact factor: 4.436

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.